cantharidin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 5743 | 56-25-7 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
The mechanism of action of cantharidin in the treatment of molluscum contagiosum is unknown.
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| July 21, 2023 | FDA | VERRICA PHARMS |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D004791 | Enzyme Inhibitors |
| MeSH PA | D007509 | Irritants |
| MeSH PA | D009676 | Noxae |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Infection caused by Molluscum contagiosum | indication | 40070004 | DOID:8867 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| CHEMBL48449 | ChEMBL_ID |
| DB12328 | DRUGBANK_ID |
| 001989 | NDDF |
| 4019021 | VANDF |
| D002193 | MESH_DESCRIPTOR_UI |
| C0006886 | UMLSCUI |
| 11470 | INN_ID |
| 437975006 | SNOMEDCT_US |
| 86218002 | SNOMEDCT_US |
| 5944 | PUBCHEM_CID |
| 1984 | RXNORM |
| D11745 | KEGG_DRUG |
| IGL471WQ8P | UNII |
| 11889 | MMSL |
| 369647 | MMSL |
| NOCODE | MMSL |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| YCANTH | HUMAN PRESCRIPTION DRUG LABEL | 1 | 71349-070 | SOLUTION | 3.20 mg | TOPICAL | NDA | 27 sections |
| YCANTH | HUMAN PRESCRIPTION DRUG LABEL | 1 | 71349-999 | SOLUTION | 3.20 mg | TOPICAL | NDA | 27 sections |
| CANTHARIDIN 0.7% | HUMAN PRESCRIPTION DRUG LABEL | 1 | 72934-9035 | LIQUID | 0.70 g | TOPICAL | unapproved drug other | 4 sections |
| CANTHARIDIN 1% / PODOPHYLLUM RESIN 5% / SALICYLIC ACID 30% | HUMAN PRESCRIPTION DRUG LABEL | 3 | 72934-9036 | LIQUID | 1 g | TOPICAL | unapproved drug other | 4 sections |